02nd April 2026
Online Community Meeting
Our next online meeting will be taking place on Thursday 23rd April 11:30-13:00 (BST – UK time).
Helping to cope, helping to hope
Established in 2004, Alex TLC provides invaluable support and information to people affected by leukodystrophy.
Formerly ALD Life, for people affected by adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN), we extended our services to support all leukodystrophies in 2019 and became Alex, The Leukodystrophy Charity.
There are more than 100 different known types of leukodystrophy, including some so rare they only affect one or two individuals. We are the only charity in the UK that provides support and information to people affected by any of the leukodystrophy conditions worldwide.
Leukodystrophies are genetic disorders primarily affecting the white matter of the central nervous system (ie. the brain or spinal cord). The majority of leukodystrophies are degenerative, causing symptoms such as impaired mobility, vision, speech and hearing, incontinence, inability to swallow and loss of cognitive skills. In some cases, they may be life limiting. These conditions affect males and females of all ages and ethnic backgrounds, most notably children.
Have you or a family member been diagnosed with a leukodystrophy?
We understand the information you have received may be new and confusing, and it may be difficult to know where to go for further advice and information.
You can help us to raise vital funds and increase awareness of leukodystrophies.
The majority of people aren’t aware of these rare diseases and their impact on individuals and their families. With your help, however small, we can make a real difference.
These pages are packed full of ideas and inspiration for the various ways you and/or your organisation can get involved and lend your support.
Discover how you can get involved today.
We are constantly updating our news section with everything of interest to people affected by leukodystrophies. You will find information about our latest work, health and research news, updates for professionals, and more.
02nd April 2026
Our next online meeting will be taking place on Thursday 23rd April 11:30-13:00 (BST – UK time).
02nd April 2026
We have planned a range of different group specific meetings over the next few months, including for parents of affected children and affected men.
30th March 2026
Please complete our Impact Survey 2026 and share your feedback. For anyone who has a connection with Alex TLC through their/the person they care for leukodystrophy.
27th March 2026
We wanted to share a recent announcement affecting those with Addison’s Disease. Hydrocortisone sodium phosphate injection (the pre-mixed hydrocortisone injection) has been discontinued.
26th March 2026
We have sent out the March edition of our monthly news round-up. This month we will be sharing about events we’ve been attending, your chance to have your say on supporting us and Ask our Community.
24th March 2026
The U.S. Food and Drug Administration (FDA) has accepted Ionis New Drug Application (NDA) for zilganersen, the investigational treatment for Alexander Disease for Priority Review.